<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5DF5258-6FC1-4F92-928B-2E970FF914D4"><gtr:id>D5DF5258-6FC1-4F92-928B-2E970FF914D4</gtr:id><gtr:name>The University of Iowa</gtr:name><gtr:address><gtr:line1>203 Van Allen Hall</gtr:line1><gtr:line4>Iowa City</gtr:line4><gtr:line5>IA 52242-1479</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2E8E7A84-3BC7-4739-986D-C05FC31789B8"><gtr:id>2E8E7A84-3BC7-4739-986D-C05FC31789B8</gtr:id><gtr:name>Charit? - University of Medicine Berlin</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Virology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5DF5258-6FC1-4F92-928B-2E970FF914D4"><gtr:id>D5DF5258-6FC1-4F92-928B-2E970FF914D4</gtr:id><gtr:name>The University of Iowa</gtr:name><gtr:address><gtr:line1>203 Van Allen Hall</gtr:line1><gtr:line4>Iowa City</gtr:line4><gtr:line5>IA 52242-1479</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2E8E7A84-3BC7-4739-986D-C05FC31789B8"><gtr:id>2E8E7A84-3BC7-4739-986D-C05FC31789B8</gtr:id><gtr:name>Charit? - University of Medicine Berlin</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/688010C3-2B37-46CF-964C-723F16116507"><gtr:id>688010C3-2B37-46CF-964C-723F16116507</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>Bryan</gtr:otherNames><gtr:surname>Reeves</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900466"><gtr:id>AFAC46B6-ADDC-453D-826E-D6DC0B88FD57</gtr:id><gtr:title>The impact of viral gene expression and cellular signalling upon the control of HCMV latency and reactivation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0900466</gtr:grantReference><gtr:abstractText>Human Cytomegalovirus is a herpes virus that co-exists within the human host for life. Usually benign in healthy adults, in certain patients whose body defence mechanism (immune system) against pathogens is switched off (i.e. transplant, cancer and AIDS patients) the virus spreads uncontrollably throughout the body. This results in severe disease and, if not brought back under control, can lead to death. 

The ultimate aim is to understand how the virus remains dormant in humans and what host signals tell the virus to awaken (?reactivate?) from its? dormant state. By understanding what the signals are which reactivate the virus we can then design therapies to intercept that signal and prevent it from telling the virus to reactivate until the patients? immune system has recovered sufficiently to regain control over the virus. Furthermore, if we can understand how the virus hijacks the cells it resides in during its? dormant phase we can hopefully, by determining what the virus needs to survive, design novel therapies that could allow us to understand what the virus needs for long term survival in the host. Such an approach may kill the virus and result in the eradication of this pathogen from humans.</gtr:abstractText><gtr:technicalSummary>Although primary infection with human Cytomegalovirus (HCMV) is usually asymptomatic in healthy individuals, infection and reactivation of immuno-suppressed AIDS, cancer and transplant patients, causes severe morbidity and mortality. Additionally, infection in utero occurs in approximately 1-2% of all live births and is associated with severe long-term consequences including blindness, deafness and mental retardation. 

Previous studies on HCMV latency and reactivation suggest that the myeloid lineage is important. HCMV establishes latency in bone-marrow progenitor cells and reactivation is linked with the differentiation state of myeloid cells whereby myeloid cell maturation induces chromatin remodelling of the major lytic (?reactivation?) promoter into an active form concomitant with reactivation. However, the apparent contradiction between efficiency of HCMV reactivation in vivo compared with studies in vitro suggests that further, yet undefined, factors augment reactivation in vivo.
 
Firstly, I propose to study the impact of chromatin remodelling of the MIEP during differentiation in the context of inflammatory signalling induced by myeloid cell maturation. Specifically, I intend to identify and characterise signalling pathways involved in reactivation. Broad spectrum chemical inhibitors will be used to identify potential pathways involved and then more detailed analyses using adenoviral vectors to introduce mutant forms of signalling proteins, siRNA technology and more specific inhibitors of points in the pathway will be carried out. These analyses will be performed in an in vitro model that has been used in previously to analyse the molecular mechanisms of HCMV reactivation. 

Secondly, I propose the further study of a recently identified transcript, UL81-82ast (LUNA), expressed during both lytic and latent infection. Preliminary data suggests that LUNA can disrupt ND10 bodies which maybe due to a potential de-sumoylase activity of the protein. To as the role of the de-sumoylase function a mutant virus within the putative active site will be characterised for its ability to establish latency and reactivate using the in vitro system. Furthermore, expression of a SUMO protease would allow HCMV to target a number of diverse processes, thus I will perform a yeast 2 hybrid assay and then characterise positive interactions to give further insight into the precise role of this protein during latency, reactivation and lytic infection. 

It is hoped that these studies will increase our understanding of how HCMV manipulates the host cell environment to so successfully establish both lytic and latent infections, and ultimately lead to the identification of key signalling pathways that promote reactivation providing a target for therapeutic intervention.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>789535</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Charit? - University of Medicine Berlin</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Paediatric and Adolescent Medicine</gtr:department><gtr:description>Understanding the function of UL138 gene expression during latency</gtr:description><gtr:id>16A53887-1C04-4CFD-AFF5-F3B3A28C0454</gtr:id><gtr:impact>No published outputs</gtr:impact><gtr:outcomeId>SuDunCCjNVj-1</gtr:outcomeId><gtr:partnerContribution>Provision of recombinant viruses and intellectual input</gtr:partnerContribution><gtr:piContribution>Using recombinant viruses to assess the regulation of TNFRI expression during latency in our experimental systems</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Novel HCMV anti-virals</gtr:description><gtr:id>996B4AED-B0DB-43BC-8C23-A24005EC3326</gtr:id><gtr:impact>A paper is in preparation</gtr:impact><gtr:outcomeId>58bd732b422991.07604987-1</gtr:outcomeId><gtr:partnerContribution>Our colleagues have provided the chemistry</gtr:partnerContribution><gtr:piContribution>We will characterise a series of anti-virals for their activity against HCMV</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular &amp; Cellular Biology</gtr:department><gtr:description>Role of ion channels in herpes virus reactivation</gtr:description><gtr:id>C76ADA6D-2FBD-49E4-91A3-96143D5A9F16</gtr:id><gtr:impact>Potential ion channel targets in HCMV reactivation have been identified for further study
We have contributed to studies of KSHV reactivation that is being prepared for submission</gtr:impact><gtr:outcomeId>jyxnneifgHP-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator has the electrophysiology experience to study the role of channels in reactivation. They are focussed on KSHV.</gtr:partnerContribution><gtr:piContribution>We will study the role of ion channels in herpes virus reactivation with our expertise in HCMV being our contributions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Iowa</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Internal Medicine</gtr:department><gtr:description>Role of Creb response Elements in HCMV reactivation</gtr:description><gtr:id>2ADA493F-E6CD-43EB-B322-B08AAA79AF12</gtr:id><gtr:impact>Oral presentation of work at scientific meetings
Work published in PLoS Pathogens (2014) - see publications list</gtr:impact><gtr:outcomeId>DnrffhuUzzD-1</gtr:outcomeId><gtr:partnerContribution>They provided the recombinant viruses</gtr:partnerContribution><gtr:piContribution>Testing the recombinant viruses in our experimental latency and reactivation systems. Using the viruses to help our ongoing work delineating the pathway of HCMV reactivation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Anti-viral activity of an MSK inhibitor</gtr:description><gtr:id>697E4782-1FCE-4578-AEDB-E17C86095765</gtr:id><gtr:impact>A paper was published in 2017 PMID:28100301</gtr:impact><gtr:outcomeId>58bd71c16a44a0.99766766-1</gtr:outcomeId><gtr:partnerContribution>They approached us to assist them with their study as they did not have the technical expertise in the area - they performed the initial characterisation of anti-viral activity</gtr:partnerContribution><gtr:piContribution>We provided research expertise in chromatin biology and transcription to help define the MoA of this compound</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Medicine</gtr:department><gtr:description>Role of LUNA in HCMV latency and reactivation</gtr:description><gtr:id>88AFD392-3BBC-4701-94FF-A86CF9C9D917</gtr:id><gtr:impact>Oral presentations at scientific meetings
Manuscript being prepared

Led to an MRC PhD studentship to pursue this work further</gtr:impact><gtr:outcomeId>GhwHmoTwFkF-1</gtr:outcomeId><gtr:partnerContribution>They are generating the recombinant viruses and characterisation of the protein function during latency</gtr:partnerContribution><gtr:piContribution>We are providing the biochemical characterisation of the LUNA protein and studies in HCMV reactivation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The natural history of HCMV and impact of latency</gtr:description><gtr:id>E3D87961-F680-45B0-9139-31CFBFF54205</gtr:id><gtr:impact>This work is just beginning but a manuscript detailing the natural history of HCMV and the correlation with latency is being prepared

we have been awarded a 5 year Wellcome Collaborator Award in which HCMV latency is an integral part (&amp;pound;2.5m)</gtr:impact><gtr:outcomeId>bUht7zizWy9-1</gtr:outcomeId><gtr:partnerContribution>The partners provide the clinical lead on this wih emphasis on the characterising the immune response to HCMV in transplant patients.</gtr:partnerContribution><gtr:piContribution>We are applying our knowledge of HCMV latency and reactivation to ongoing studies of the immune response to HCMV in transplant patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Viral modulation of neutrophil viability</gtr:description><gtr:id>31A56A63-3F82-46E5-8DD7-4307530E23CF</gtr:id><gtr:impact>Abstract submitted for Oral presentation at International respiratory meeting

Manuscript submitted to Blood

The research has led to support for two PhD positions supported by the Gates Foundation and a CTRF from the MRC to pursue aspects of this study further</gtr:impact><gtr:outcomeId>CRqJbkfYPxU-1</gtr:outcomeId><gtr:partnerContribution>Expertise with neutrophil isolation and assaying of function</gtr:partnerContribution><gtr:piContribution>We have provided our expertise in the understanding of HCMV biology to use the virus as a tool to probe the cellular functions that are intrinsic for the viability and function of neutrophils.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Structural insight into the biology of HCMV encoded protein</gtr:description><gtr:id>263028CD-CF85-4DFD-BF3F-A261466C1492</gtr:id><gtr:impact>No direct outputs yet</gtr:impact><gtr:outcomeId>56bc749ead04d2.36800304-1</gtr:outcomeId><gtr:partnerContribution>The partners are cloning and purifying the protein for structural studies to determine a) the structure of the protein b) the structure of the functional mutant we have identified and c) the structural relationship of the protein with functional homologues encoded by the cell</gtr:partnerContribution><gtr:piContribution>We provide the biological knowledge on the protein. We identified the protein function and the key motifs responsible for it's activity</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life and Medical Sciences</gtr:department><gtr:description>Cyclophilins and HCMV</gtr:description><gtr:id>EFE4D12D-BE92-4386-9342-D2B7994D33C1</gtr:id><gtr:impact>This collaboration is part of a larger collaborative project that simultaneously seeks to define the molecular biology of cyclophilins in multiple viruses whilst generating new compounds as therapeutics and is collaboration between virology and chemistry.

These studies have been submitted for Wellcome Trust SDDI grant/ MRC DPFS awards

We have secured BRC funding to explore this work for 3 years (&amp;pound;199,500)</gtr:impact><gtr:outcomeId>546487e0a53178.89854387-1</gtr:outcomeId><gtr:partnerContribution>This work was led by Prof Towers and his studies on HIV. By studying HCMV in parallel we aim to identify commonalities between different virus families to direct future strategies for pan anti-viral treatments</gtr:partnerContribution><gtr:piContribution>We are pursuing the role of cyclophilins in HCMV biology and how we can modulate their function to expose the virus to the activity of anti-viral therapeutics. This is part of a broader aim to develop novel strategies for targeting viruses by enhancing the immune response against them.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Medicine</gtr:department><gtr:description>Viral regulaiton of 41BBL expression for immune evasion</gtr:description><gtr:id>3EF85E08-6E3E-4203-BFB4-25F51C2AC0B5</gtr:id><gtr:impact>Oral presentations at scientific meetings

Manuscript in preparation

PhD thesis being prepared</gtr:impact><gtr:outcomeId>ZTwWckEGhms-1</gtr:outcomeId><gtr:partnerContribution>Primary supervisor and immunology expertise</gtr:partnerContribution><gtr:piContribution>Intellectual input in to PhD project and providing supervision and molecular biology training</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life and Medical Sciences</gtr:department><gtr:description>Role of monocyte subsets in HCMV biology</gtr:description><gtr:id>8E153AD7-4E48-4947-97D5-74CB79FE60DA</gtr:id><gtr:impact>We have established preliminary data that is being prepared for a joint Wellcome Investigator grant application</gtr:impact><gtr:outcomeId>5464889bdaa789.94290531-1</gtr:outcomeId><gtr:partnerContribution>The collaborator is an expert in monocyte biology and defines and isolates the cell populations for our studies</gtr:partnerContribution><gtr:piContribution>We are studying the carriage of HCMV in monocytic cell sub-populations using our expertise in the study of HCMV latency in naturally latent individuals</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Role of ion channels in lytic viral replication</gtr:description><gtr:id>E32900E5-E7BC-4955-9708-154D50878B12</gtr:id><gtr:impact>We have initiated a second collaboration with the Translational Research Office at UCL to synthesise next generation analogues of the tool compound to determine if we can identify active component and b) improve activity of the compound

This work is now supported by an MRC PhD studentship</gtr:impact><gtr:outcomeId>56bc75a1a3d5e1.17626534-1</gtr:outcomeId><gtr:partnerContribution>Academic input on the initial triage of ion channel inhibitors - Electrophysiology expertise</gtr:partnerContribution><gtr:piContribution>We are studying the role of chloride ion channels in HCMV infection - we have identified a novel target that could be a potential therapeutic target to control CMV infection in vivo</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Hosting School visiting UCL</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DE176DB2-F207-48B1-9C55-52A99A1A162A</gtr:id><gtr:impact>Local schools are hosted at UCL (organised by Richard Milne &amp;amp; Greg Towers) where they come to meet Infection &amp;amp; Immunity Researchers. They learn about infective agents - have hands on practicals demonstrating the spread of disease by sneezing and failure to hand wash (talc and hair gel, respectively) and then after a talk about what makes a pathogen a pathogen they work with members of the research community to design their own pathogens and describe them to the rest of the group. This gives them the chance to interact with different members of research teams (my lab was represented by undergraduates, post graduates and myself).

This activity occurs frequently in the UCL cycle and is part of a greater effort for UCL researchers to inspire the next generation of researchers</gtr:impact><gtr:outcomeId>56bc7ac27ba7c2.18409295</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute Immunity &amp; Transplantation open day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C238E5E7-EABE-4291-B664-B7F6337419F2</gtr:id><gtr:impact>The open days are multiple and are designed to give local people the opportunity to find out what research is being performed. A similar workshop is held for A-Level students to again inspire the next generation of researchers and tell them about the current scientific research being performed at the Institute.</gtr:impact><gtr:outcomeId>56bc7b6b5b3fe6.31541544</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leonardo Da Vinci Scholarship</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9B26D263-6494-422E-A780-E8475924BF4A</gtr:id><gtr:outcomeId>eJbgPpwmrQm0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>BRC rapid response</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C9E8B45D-ABB9-4EBF-BADB-FBA287B935AE</gtr:id><gtr:outcomeId>58bd73dd4c06d7.12207203</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FEMS Travel Award</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Federation of European Microbiological Societies (FEMS)</gtr:fundingOrg><gtr:id>B421360A-EFA3-4B63-B589-B8A486A7B2AD</gtr:id><gtr:outcomeId>EJWiyNMnVn10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9375</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Peter Samuel Fund</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Royal Free Hospital</gtr:fundingOrg><gtr:id>31B6CBFD-D9D4-400E-A369-D4E2E7FB7767</gtr:id><gtr:outcomeId>546489456a5600.47209083</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bench to Bedside Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1B041703-3E9B-4D84-88CF-F9E39A81EE07</gtr:id><gtr:outcomeId>56bc7d0738eaf4.08333577</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Trust Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>50CD6601-0F09-4AB4-B255-B1008724439E</gtr:id><gtr:outcomeId>54648987d1c855.50859911</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Free Bursary</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Royal Free Hospital</gtr:fundingOrg><gtr:id>178D89E1-1CE3-433C-AF8E-68216C178C3F</gtr:id><gtr:outcomeId>546489d139b707.11612558</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>185000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CTRF</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F8044EA9-5449-4ABF-9DBB-26A360990093</gtr:id><gtr:outcomeId>GCsnya4Sj8X</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2567000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Collaborator Award</gtr:description><gtr:end>2022-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>BD7D6FB5-03D8-4B1F-80DE-931C2021DC91</gtr:id><gtr:outcomeId>58bd741ea24b53.17686909</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7A44EFE8-C4C4-48D4-8BB0-037C73BAC7E9</gtr:id><gtr:title>Islands of linkage in an ocean of pervasive recombination reveals two-speed evolution of human cytomegalovirus genomes</gtr:title><gtr:parentPublicationTitle>Virus Evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c22e47a7a8631b7717909340847ef61"><gtr:id>4c22e47a7a8631b7717909340847ef61</gtr:id><gtr:otherNames>Lassalle F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a69f6a2631333.62862139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E095C4C8-6C5C-47AD-9132-3A7992BEB10A</gtr:id><gtr:title>Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/791088abb6d8f720eb8d8a2d54f14b85"><gtr:id>791088abb6d8f720eb8d8a2d54f14b85</gtr:id><gtr:otherNames>Huang MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13478_28_22647696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72A0255D-344F-4E36-A8BA-69634E5B5914</gtr:id><gtr:title>Chromatin-mediated regulation of cytomegalovirus gene expression.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>VWZd4bsp4h4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E50C2D42-E257-4396-9D5D-A71D01037F13</gtr:id><gtr:title>Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoter.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_13478_28_23736881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB0967DF-81C7-42BD-86D0-AE4445CA76E9</gtr:id><gtr:title>Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5464830f926999.11361852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B25097D-2F78-41D7-8604-96AD77567DC4</gtr:id><gtr:title>The intimate relationship between human cytomegalovirus and the dendritic cell lineage.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>546482b9120292.91288455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC09E831-47D2-492F-B0E9-1246A9FAE721</gtr:id><gtr:title>LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latency.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdef4461acff11f7ef21d9ae01cbd06c"><gtr:id>bdef4461acff11f7ef21d9ae01cbd06c</gtr:id><gtr:otherNames>Kew VG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a69f50e5832b2.60732143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F57A9B92-B4DD-4493-94CC-22BF59EECB1F</gtr:id><gtr:title>Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>TNCNg8q3S6L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>892A08CD-199B-4C8F-9E4D-B8858358465E</gtr:id><gtr:title>Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5464830f6fb8d9.15795230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35B2F6E1-0D3E-45B5-B5F2-F01E53D1C830</gtr:id><gtr:title>The pathogenesis of human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d063aa568ceb15d505533d7624e31c78"><gtr:id>d063aa568ceb15d505533d7624e31c78</gtr:id><gtr:otherNames>Griffiths P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>546482b935d510.85966320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>241EFEC7-023D-4CB5-BF12-559B70A7616C</gtr:id><gtr:title>Cytomegalovirus latency and reactivation: recent insights into an age old problem.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbed47c6fd1b28a33db5f957c8a7d993"><gtr:id>bbed47c6fd1b28a33db5f957c8a7d993</gtr:id><gtr:otherNames>Dupont L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>585d557767c878.97589126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC57CF97-C7A2-4E3E-B71F-C76A04FABA38</gtr:id><gtr:title>Rapamycin does not inhibit human cytomegalovirus reactivation from dendritic cells in vitro.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6217a09619e18e6ded648bc1b7305dc2"><gtr:id>6217a09619e18e6ded648bc1b7305dc2</gtr:id><gtr:otherNames>Glover TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>546482b8e0cfa1.11001128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>198F8CB2-2EF8-4776-99A7-4063C6575F67</gtr:id><gtr:title>Human cytomegalovirus manipulation of latently infected cells.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0b3db78c0d3f2b49bc012cf14cf4a65"><gtr:id>a0b3db78c0d3f2b49bc012cf14cf4a65</gtr:id><gtr:otherNames>Sinclair JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>546482b8640c60.28060366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BB10EF9-3B2A-4A7A-A6FB-CADA99C8955C</gtr:id><gtr:title>The use of primary human cells (fibroblasts, monocytes, and others) to assess human cytomegalovirus function.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdc40f0f8c6b621c5ccc76e7dcc36da"><gtr:id>4bdc40f0f8c6b621c5ccc76e7dcc36da</gtr:id><gtr:otherNames>Poole E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>546482b888ed72.51370547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29F09163-14D6-4DC2-8FBE-65ECCF738F71</gtr:id><gtr:title>Cytomegalovirus from Molecular Pathogenesis to Intervention</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-1-908230-18-8</gtr:isbn><gtr:outcomeId>5464859925dc36.31125109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62F2507B-E517-4EF3-8BFA-76C8F210A271</gtr:id><gtr:title>High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aafe1950d0c5397d3665bebfe10ba852"><gtr:id>aafe1950d0c5397d3665bebfe10ba852</gtr:id><gtr:otherNames>Khan AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>58bd70a7583f57.29799367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C3803D9-7BA7-412C-9CE2-343CF74CBD27</gtr:id><gtr:title>HCMV activation of ERK-MAPK drives a multi-factorial response promoting the survival of infected myeloid progenitors.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/219f1a7fd958c5bccf23de31826a87b7"><gtr:id>219f1a7fd958c5bccf23de31826a87b7</gtr:id><gtr:otherNames>Kew V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2241-0090</gtr:issn><gtr:outcomeId>5a31dc40540e36.71392440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>782670B0-8E61-45A7-93BD-0218D9B0A7A6</gtr:id><gtr:title>Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdef4461acff11f7ef21d9ae01cbd06c"><gtr:id>bdef4461acff11f7ef21d9ae01cbd06c</gtr:id><gtr:otherNames>Kew VG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>546482b8bcb478.17136203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6765844-F854-4B4D-9213-0ADA9CA749DD</gtr:id><gtr:title>Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a037d7821ccce5bd0d7860bab19515c"><gtr:id>5a037d7821ccce5bd0d7860bab19515c</gtr:id><gtr:otherNames>Baraniak IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>5a9826f894b036.43822154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F64EEE3-46E8-49CC-BDDC-EA24B4655EAF</gtr:id><gtr:title>Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13478_28_23885077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6613C8C-F5A7-42BD-B578-A44FA8797BD5</gtr:id><gtr:title>Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>MMfxcD9BudX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15692A06-277F-4A5D-B80E-854014E3A164</gtr:id><gtr:title>Human Cytomegalovirus Delays Neutrophil Apoptosis and Stimulates the Release of a Prosurvival Secretome.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3aef83bbb2774fa038f41c1fe6bb0a"><gtr:id>4e3aef83bbb2774fa038f41c1fe6bb0a</gtr:id><gtr:otherNames>Pocock JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a69f6db3b39f6.86194775</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900466</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>